Patent · US Active

Nucleic acids encoding a deletion variant of uPAR

US8461321B2 · kind B2 · utility

0Cited by
1References
12Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 30, 2008
Grant dateJun 11, 2013
Priority date
Expiry dateOct 19, 2030

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/34
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This invention relates to the production of specific antibodies for the detection of human tumor associated urokinase-type plasminogen activator receptor (uPAR) deletion variants in biological samples as well as to their diagnostic and therapeutic application.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.